NovaBay Pharmaceuticals (NBY)

• Market cap: $6.61M
• 1 day: 0.92%
• 5 days: -9.84%
• 1 month: -9.84%
• 3 months: 80.33%
• 6 months: 88.23%
• Year to date: 76%
• 1 year: 45.5%
• 5 years: -99.83%
• 10 years: -99.98%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.

Employees: 14